# Biomat USA, Inc. – FDA Inspection, Nov 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cece048d-42be-4865-95d2-54985f6280fc
Source feed: FDA_Inspections

> FDA inspection 1071532 of Biomat USA, Inc., November 13, 2018. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 606 and 630. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1071532
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-11-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1001534 - 2016-11-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f6dcc794-a4be-4c5a-abce-28e60662e27f)
- FDA Inspection 935254 - 2015-07-02
- FDA Inspection 886548 - 2014-07-03
- FDA Inspection 797851 - 2012-09-06

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/barbara-t-carmichael/4c451805-e327-450d-b2e5-48a40f6232fe)
- [FDA Associated Person](https://www.keypedia.com/people/julie-d-bringger/4f6b1f96-e559-45bd-bb73-5354ce64552d)
- Issuing Officer

Company: https://www.keypedia.com/companies/biomat-usa-inc/0f3284af-052d-44ca-aace-d6e7aef69b44

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
